Buy and Bill Brief
Payer Site-of-Care Redirection Programs and Revenue Impact
Payer rules now dictate both where infusions happen and how practices get paid for them.
Mei-Lin Tsou
340B and Site-of-Care Financial Interaction in Mixed-Setting Platforms
Hospital outpatient sites earn 340B spreads while independent centers absorb full drug costs.
Mei-Lin Tsou
HRSA Audit Risk and 340B Compliance Documentation for Infusion Groups
Infusion programs face predictable audit failures in administrative compliance and documentation.
Darius Okonkwo
HOPD vs Freestanding Infusion Center Reimbursement Comparison
Facility fees widen the reimbursement gap between hospitals and freestanding infusion centers.
Darius Okonkwo
340B Contract Pharmacy Rules and Infusion Center Compliance
Covered entities must embed 340B rules into infusion workflows to stay compliant.
Darius Okonkwo
Freestanding Infusion Center Chair Economics and Revenue per Visit
Profitability depends on drug margin, billing accuracy, and payer management—not just filling seats.
Mei-Lin Tsou
State-Level 340B Payer Access Laws and Infusion Reimbursement
State laws protecting 340B drug discounts face uneven legal enforceability across jurisdictions.
Mei-Lin Tsou